Restoration of Immune Surveillance in Prostate Cancer Prevention by Sulforaphane in Hi-Myc Mice

Krishna B Singh1, Eun-Ryeong Hahm1, Joshi J Alumkal2

  • 1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

PubMed

Insights

Sulforaphane (SFN), a broccoli compound, restores immune surveillance in a prostate cancer mouse model by increasing CD8+ T cells and dendritic cells. SFN also reduced immunosuppressive cells and inflammatory cytokines, suggesting a role in cancer prevention.

Area of Science:

  • Oncology
  • Immunology
  • Nutritional Science

Background:

  • Sulforaphane (SFN) is a broccoli constituent with demonstrated preclinical efficacy in preventing prostate cancer.
  • The precise mechanisms by which SFN exerts its chemopreventive effects, particularly regarding immune modulation, remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of oral SFN administration on immune surveillance in a relevant prostate cancer mouse model (Hi-Myc mice).
  • To elucidate the immunomodulatory effects of SFN in the context of prostate cancer development and progression.

Main Methods:

  • Hi-Myc mice were treated with SFN orally for 16 weeks.
  • Flow cytometry was used to quantify immune cell populations (CD8+ T cells, CD4+ T cells, dendritic cells, NK cells, myeloid-derived suppressor cells) within prostate tumors.
  • Plasma levels of various cytokines and chemokines were measured.
  • In vitro studies assessed the effect of SFN on cancer cell proliferation with and without cytokine supplementation.

Main Results:

  • SFN treatment significantly increased prostate tumor-infiltrating CD8+ T cells (1.33-fold) and dendritic cells (57%).
  • SFN administration led to a significant decrease (approximately 30%) in myeloid-derived suppressor cells within prostate tumors.
  • Plasma levels of several pro-inflammatory cytokines (e.g., IL-1β, IL-4) were significantly reduced in SFN-treated mice.
  • SFN's in vitro inhibition of cancer cell proliferation was partially reversed by IL-4 and IL-13.

Conclusions:

  • Oral SFN administration restores immune surveillance in the Hi-Myc mouse model of prostate cancer.
  • SFN modulates the tumor immune microenvironment by enhancing anti-tumor immunity and reducing immunosuppression.
  • These findings support the potential of SFN as a dietary intervention for prostate cancer prevention through immune system modulation.